SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023285
Filing Date
2017-11-09
Accepted
2017-11-09 16:34:01
Documents
72
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20170930.htm 10-Q 1567990
2 EX-10.1 achv-ex101_1096.htm EX-10.1 194665
3 EX-31.1 achv-ex311_9.htm EX-31.1 9046
4 EX-31.2 achv-ex312_7.htm EX-31.2 9082
5 EX-32.1 achv-ex321_6.htm EX-32.1 4842
6 EX-32.2 achv-ex322_8.htm EX-32.2 4867
  Complete submission text file 0001564590-17-023285.txt   6676905

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT achv-20170930.xml EX-101.INS 1335203
8 XBRL TAXONOMY EXTENSION SCHEMA achv-20170930.xsd EX-101.SCH 55446
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20170930_cal.xml EX-101.CAL 60160
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20170930_def.xml EX-101.DEF 222266
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20170930_lab.xml EX-101.LAB 423839
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20170930_pre.xml EX-101.PRE 355988
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 171191362
SIC: 2835 In Vitro & In Vivo Diagnostic Substances